175 related articles for article (PubMed ID: 20564074)
1. Prognostic value of mucin 4 expression in colorectal adenocarcinomas.
Shanmugam C; Jhala NC; Katkoori VR; Wan W; Meleth S; Grizzle WE; Manne U
Cancer; 2010 Aug; 116(15):3577-86. PubMed ID: 20564074
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
[TBL] [Abstract][Full Text] [Related]
5. Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.
Fu H; Liu Y; Xu L; Chang Y; Zhou L; Zhang W; Yang Y; Xu J
Medicine (Baltimore); 2016 Apr; 95(17):e3225. PubMed ID: 27124015
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody.
Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
Surgery; 2002 May; 131(5):541-7. PubMed ID: 12019408
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
[TBL] [Abstract][Full Text] [Related]
8. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
[TBL] [Abstract][Full Text] [Related]
9. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
10. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
[TBL] [Abstract][Full Text] [Related]
12. MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival.
Kwon KY; Ro JY; Singhal N; Killen DE; Sienko A; Allen TC; Zander DS; Barrios R; Haque A; Cagle PT
Arch Pathol Lab Med; 2007 Apr; 131(4):593-8. PubMed ID: 17425390
[TBL] [Abstract][Full Text] [Related]
13. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
16. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
18. Flat and polypoid adenocarcinomas of the colorectum: A comparative histomorphologic analysis of 47 cases.
Nasir A; Boulware D; Kaiser HE; Bodey B; Siegel S; Crawley S; Yeatman T; Marcet JE; Coppola D
Hum Pathol; 2004 May; 35(5):604-11. PubMed ID: 15138936
[TBL] [Abstract][Full Text] [Related]
19. Do young patients with colorectal cancer have a poorer prognosis than old patients?
Li M; Li JY; Zhao AL; Gu J
J Surg Res; 2011 May; 167(2):231-6. PubMed ID: 21316708
[TBL] [Abstract][Full Text] [Related]
20. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]